The Topical and Injected Antibiotics for HS

What Is Hidradenitis Suppurativa, and Why Start With Antibiotics?

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease centered on hair follicles in areas with apocrine glands — the armpits, groin, under the breasts, and buttocks — where blocked follicles rupture and trigger a cycle of inflammation, painful nodules, abscesses, and, over time, tunnels under the skin 1Ref 1Sabat R, Jemec GBE, Matusiak Ł, et al. (2020).Hidradenitis suppurativa.Definition and follicular/immune-driven mechanism of hidradenitis suppurativa; that it is not caused by poor hygiene and is frequently misdiagnosed as recurring boils early in its course.. It is not caused by poor hygiene and is not contagious, though it is frequently mistaken early on for recurring boils, which can delay real treatment for years 1Ref 1Sabat R, Jemec GBE, Matusiak Ł, et al. (2020).Hidradenitis suppurativa.Definition and follicular/immune-driven mechanism of hidradenitis suppurativa; that it is not caused by poor hygiene and is frequently misdiagnosed as recurring boils early in its course..

Topical and intralesional antibiotics target that inflammatory cycle more than any bacterial infection. HS behaves like an inflammatory disease first and an infectious one second, and part of why an antibiotic such as clindamycin helps is its own anti-inflammatory action on the follicular unit — not only its effect on bacteria 1Ref 1Sabat R, Jemec GBE, Matusiak Ł, et al. (2020).Hidradenitis suppurativa.Definition and follicular/immune-driven mechanism of hidradenitis suppurativa; that it is not caused by poor hygiene and is frequently misdiagnosed as recurring boils early in its course..

How Is HS Staged, and Where Do Local Treatments Fit?

Hidradenitis suppurativa is staged with the Hurley system, which groups disease by how far it has progressed: isolated nodules and abscesses with no tunnels (Hurley I), multiple recurrent lesions with early tunnel formation but no widespread scarring (Hurley II), or diffuse, interconnected tunnels across an entire region (Hurley III) 2Ref 2Alikhan A, Sayed C, Alavi A, et al. (2019).North American clinical management guidelines for hidradenitis suppurativa: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.Hurley staging system for hidradenitis suppurativa severity, and that local/procedural management options such as intralesional injection are positioned for milder, non-tunneling stages of disease.. Topical and intralesional antibiotics are used almost entirely for Hurley I and early Hurley II disease, where the problem is still a handful of discrete, inflamed spots rather than an underlying network of tunnels that no cream or injection can reach 2Ref 2Alikhan A, Sayed C, Alavi A, et al. (2019).North American clinical management guidelines for hidradenitis suppurativa: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.Hurley staging system for hidradenitis suppurativa severity, and that local/procedural management options such as intralesional injection are positioned for milder, non-tunneling stages of disease..

Staging hidradenitis and matching the right local, systemic, or surgical option to that stage is the logic behind the entire hs treatment ladder: local measures for the mildest disease, systemic medication as lesions multiply or tunnel, and surgery for tissue that has already been replaced by scar.

How Is Topical Clindamycin Used for Mild HS?

Topical clindamycin lotion or solution is applied directly to inflamed skin for mild, Hurley I hidradenitis — a handful of tender bumps without tunnels. It doesn't require needles or an extra office visit for every flare, which makes it a practical first prescription once antiseptic washes and lifestyle changes alone stop controlling symptoms.

The lotion works at the skin surface rather than through the bloodstream the way an oral antibiotic does, which is also why it does little for a nodule that has already tunneled beneath the skin. Anyone with more than a few active spots, or any sign of tunnel formation, has usually moved past what a topical alone can control 2Ref 2Alikhan A, Sayed C, Alavi A, et al. (2019).North American clinical management guidelines for hidradenitis suppurativa: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.Hurley staging system for hidradenitis suppurativa severity, and that local/procedural management options such as intralesional injection are positioned for milder, non-tunneling stages of disease..

Courses are typically measured in weeks, not months, and reassessment matters: skin that shows no change after a full course is a signal to switch approach rather than to keep refilling the same prescription. Long, open-ended use of any topical antibiotic also carries the same resistance concern as oral antibiotics, which is one reason clinicians tend to pair it with a non-antibiotic step — an antiseptic wash, benzoyl peroxide, or a steroid injection for any single stubborn nodule — rather than leaning on clindamycin alone indefinitely.

What Does an Intralesional Steroid Injection Do for a Painful Nodule?

An intralesional corticosteroid injection delivers medication directly into a single inflamed nodule, and it is one of the procedural management options guidelines describe for acute HS flares 2Ref 2Alikhan A, Sayed C, Alavi A, et al. (2019).North American clinical management guidelines for hidradenitis suppurativa: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.Hurley staging system for hidradenitis suppurativa severity, and that local/procedural management options such as intralesional injection are positioned for milder, non-tunneling stages of disease.. Rather than treating the whole affected area the way a topical or oral medication does, the injection targets one lesion — often shrinking the swelling and pain within days, well before oral or topical treatment would show any effect.

It is a short in-office procedure, not something done at home, and it treats the nodule that is already there rather than preventing the next one from forming. Clinicians often reach for it around a flare, covered in more detail in getting through a hidradenitis flare, while longer-term control still depends on the rest of the treatment plan.

When Do Topical and Local Treatments Stop Being Enough?

Topical clindamycin and steroid injections are built for a small number of discrete lesions, not for disease that keeps producing new nodules, spreads to a second body area, or has already formed tunnels. When that happens, the next tier is systemic — oral antibiotics, the antibiotic combinations that quiet hs at a body-wide level, typically a rifampin-clindamycin pairing, or, for moderate-to-severe disease that still doesn't respond, a biologic.

The clearest evidence for moving beyond local and oral treatment comes from trials of adalimumab, a biologic that significantly increased the share of patients reaching a meaningful clinical response by three months compared with placebo, in moderate-to-severe disease that had not responded to antibiotics 3Ref 3Kimball AB, Okun MM, Williams DA, et al. (2016).Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.PIONEER I and II trial evidence that adalimumab significantly increases clinical response versus placebo at week 12 in moderate-to-severe HS, supporting biologic escalation after antibiotics fail.. That is a real, measured difference rather than a theoretical option, which is why current guidelines treat biologics as a genuine tier. Knowing when to start biologic for hidradenitis is really a question of how many earlier tiers have already been tried without lasting control, and how much of the disease pattern — new lesions, spreading area, tunnel formation — has moved beyond what a local or oral course was ever designed to fix.

What Are the Limits of Treating HS at Home, Locally?

Topical and intralesional treatment can quiet individual lesions, but neither addresses the tunnels, scarring, or recurring drainage that define more advanced HS, and neither substitutes for the daily care that keeps flares from starting in the first place. HS is also commonly missed or mislabeled for years before diagnosis — hidradenitis suppurativa misdiagnosed as boils is a well-documented pattern — so a lesion that keeps failing what looks like standard boil treatment is worth a second look rather than a third round of the same antibiotic.

Daily care between flares matters as much as any single prescription: consistent gentle cleansing, friction and weight management, and smoking cessation where relevant are part of finding the best wash for hidradenitis suppurativa and the broader routine that keeps mild disease mild. None of that is a cure, but it changes how often the antibiotics and injections above are even needed.